Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)

NCT05579626 · clinicaltrials.gov ↗

PHASE4

Phase

ENROLLING_BY_INVITATION

Status

4000

Enrollment

OTHER

Sponsor class

Conditions

Pre Diabetes
ASCVD

Interventions

DRUG: high-intensity statin arm
DRUG: low-intensity statin plus ezetimibe

Sponsor

Seung-Whan Lee, M.D., Ph.D.

Collaborators

Yuhan Corporation